Abstract
Calprotectin is member of the S-100 protein family with a wide plethora of intra-and extracellular functions. Anticancer activities, antimicrobial effects and being a qualified disease marker are among the compelling features of this protein to be used as a pharmaceutical agent. However, there are several impediments to applications of protein pharmaceuticals including: proteolytic degradation, short circulating half-life, low solubility and immunogenicity. Pegylation is a common bioconjugation polymer capable of overcoming these drawbacks. Recombinant expression and purification of calprotectin along with its pegylation would result in enhanced pharmaco-dynamic and pharmacokinetic properties. Our florescence spectroscopy and far Ultraviolet-optical density results indicate that pegylation altered the physical and structural properties of the calprotectin to become in a more stable and functionally active state. Due to enhanced pharmacodynamic and pharmacokinetic properties of the calprotectin via pegylation, this study would pave the way for better in vitro and in vivo validations of calprotectin applications in medical practice.
Similar content being viewed by others
Abbreviations
- CD:
-
Circular dichroism
- IPTG:
-
Isopropyl-thio-β-d-galactoside
- mPEG:
-
Methoxy poly ethylene glychol
- MRP:
-
Myeloid inhibitory factor related protein
- Ni2+-NTA:
-
Nickel-nitrilotriacetic acid
- PEG:
-
Polyethylene glycol
- SDS PAGE:
-
Sodium dodecyl sulphate polyacrylamide gel electrophoresis
References
Kligman D, Hilt DC (1988) The S100 protein family. Trends Biochem Sci 13(11):437–443
Clohessy P, Golden B (1995) Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol 42(5):551–556
Nisapakultorn K, Ross KF, Herzberg MC (2001) Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect Immun 69(6):3692–3696
Bhardwaj RS, Zotz C, Roth J, Goebeler M, Mahnke K, Falk M, Meinardus-Hager G, Sorg C, Zwadlo-Klarwasser G (1992) The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur J Immunol 22(7):1891–1897
Kalia J, Raines RT (2010) Advances in bioconjugation. Curr Org Chem 14(2):138
Syed S, Schuyler PD, Kulczycky M, Sheffield WP (1997) Potent antithrombin activity and delayed clearance from the circulation characterize recombinant hirudin genetically fused to albumin. Blood 89(9):3243–3252
Lyczak J, Morrison S (1994) Biological and pharmacokinetic properties of a novel immunoglobulin-CD4 fusion protein. Arch Virol 139(1–2):189–196
Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R (1991) Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm Res 8(6):713–720
Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54(4):459–476
Zalipsky S, Seltzer R, Menon-Rudolph S (1992) Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins. Biotechnol Appl Biochem 15(1):100–114
Zalipsky S, Lee C (1992) Use of functionalized poly (ethylene glycol) s for modification of polypeptides. In: Poly (Ethylene Glycol) Chemistry. Springer, pp 347–370
Abuchowski A, van Es T, Palczuk NC, Davis FF (1977) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 252(11):3578–3581
Gallagher SR, Wiley EA (2008) Current protocols essential laboratory techniques. (Wiley, 2007). Appendix 2
Asghari H, Chegini KG, Amini A, Gheibi N (2016) Effect of poly and mono-unsaturated fatty acids on stability and structure of recombinant S100A8/A9. Int J Biol Macromol 84:35–42. doi:10.1016/j.ijbiomac.2015.11.065
Gheibi N, Asghari H, Chegini KG, Sahmani M, Moghadasi M (2016) The Role of Calcium in the Conformational Changes of the Recombinant S100A8/S100A9. Mol Biol 50(1):136–142. doi:10.7868/s0026898415060087
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685
Crestfield AM, Moore S, Stein WH (1963) The preparation and enzymatic hydrolysis of reduced and S-carboxymethylated proteins. J Biol Chem 238(2):622–627
Heizmann C (1992) Calcium-binding proteins: basic concepts and clinical implications. Gen Physiol Biophys 11(5):411–425
Nacken W, Roth J, Sorg C, Kerkhoff C (2003) S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 60(6):569–580
Yousefi R, Imani M, Ardestani SK, Saboury AA, Gheibi N, Ranjbar B (2007) Human calprotectin: effect of calcium and zinc on its secondary and tertiary structures, and role of pH in its thermal stability. Acta Biochim et Biophys Sin 39(10):795–802
Viseu MI, Carvalho TI, Costa SM (2004) Conformational transitions in β-lactoglobulin induced by cationic amphiphiles: equilibrium studies. Biophys J 86(4):2392–2402
Yui S, Nakatani Y, Mikami M (2003) Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 26(6):753–760
Kehl-Fie TE, Chitayat S, Hood MI, Damo S, Restrepo N, Garcia C, Munro KA, Chazin WJ, Skaar EP (2011) Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell Host Microbe 10(2):158–164
Sohnle PG, Hunter MJ, Hahn B, Chazin WJ (2000) Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor—related proteins 8 and 14). J Infect Dis 182(4):1272–1275
Hayden JA, Brophy MB, Cunden LS, Nolan EM (2012) High-affinity manganese coordination by human calprotectin is calcium-dependent and requires the histidine-rich site formed at the dimer interface. J Am Chem Soc 135(2):775–787
Mørk G, Schjerven H, Mangschau L, Søyland E, Brandtzaeg P (2003) Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes. Br J Dermatol 149(3):484–491
Korndörfer IP, Brueckner F, Skerra A (2007) The crystal structure of the human (S100A8/S100A9) 2 heterotetramer, calprotectin, illustrates how conformational changes of interacting α-helices can determine specific association of two EF-hand proteins. J Mol Biol 370(5):887–898
Vogl T, Leukert N, Barczyk K, Strupat K, Roth J (2006) Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim et Biophys Acta 1763(11):1298–1306
Vogl T, Roth J, Sorg C, Hillenkamp F, Strupat K (1999) Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 10(11):1124–1130
Davis FF (2002) The origin of pegnology. Adv Drug Deliv Rev 54(4):457–458
Veronese FM, Harris JM (2002) Introduction and overview of peptide and protein pegylation. Adv Drug Deliv Rev 54(4):453–456
Harris JM (1992) Poly (Ethylene Glycol) chemistry, biotechnical and biomedical applications, vol 59. Plenum Publishing, New York, pp xxi 385
Katre NV (1993) The conjugation of proteins with polyethylene glycol and other polymers: altering properties of proteins to enhance their therapeutic potential. Adv Drug Deliv Rev 10(1):91–114
Veronese FM (2001) Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22(5):405–417
Shafer SG, Harris SGJM (1986) Preparation of cyanuric-chloride activated poly(ethylene glycol). J Polym Sci Part A Poly Chem 24(2):375–378. doi:10.1002/pola.1986.080240214
Ross JR (1991) Practical handbook of biochemistry and molecular biology. In: Fasman GD (ed) Biochemical education. CRC Press, Boca Raton, Florida, USA. $00 ISBN 0-8493-3705-4. 19(2):95–96. doi:10.1016/0307-4412(91)90020-9
Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A (2004) Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 20(7):813–819
Brinkley M (1992) A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents. Bioconjugate Chem 3(1):2–13
Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL (1994) Expression of MRP14, 27E10, interferon-α and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J Neuroimmunol 50(2):195–201
Bernstein SL, Wyttenbach T, Baumketner A, Shea J-E, Bitan G, Teplow DB, Bowers MT (2005) Amyloid β-protein: monomer structure and early aggregation states of Aβ42 and its Pro19 alloform. J Am Chem Soc 127(7):2075–2084
Hope J, Shearman MS, Baxter HC, Chong A, Kelly SM, Price NC (1996) Cytotoxicity of prion protein peptide (PrP 106–126) differs in mechanism from the cytotoxic activity of the Alzheimer’s disease amyloid peptide, Aβ25–35. Neurodegeneration 5(1):1–11
Ishikawa K, Nakagawa A, Tanaka I, Suzuki M, Nishihira J (2000) The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9 Å resolution. Acta Crystallogr Sect D Biol Crystallogr 56(5):559–566
Acknowledgments
The authors wish to thank Qazvin University of medical sciences for supporting the conduct of this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interests.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Shahsavari, A., Azad, M., Mobarra, N. et al. Calprotectin Pegylation Enhanced Its Physical and Structural Properties. Protein J 35, 363–370 (2016). https://doi.org/10.1007/s10930-016-9680-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-016-9680-z